SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-21-000823
Filing Date
2021-01-11
Accepted
2021-01-11 17:49:17
Documents
2
Period of Report
2021-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 20345
2 EXHIBIT 24 brhc10018724_ex24.htm EX-24 4903
  Complete submission text file 0001140361-21-000823.txt   26594
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Issuer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CYCLERION THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR CAMBRIDGE MA 02142
Business Address
Gjino Anjeza (Reporting) CIK: 0001839068 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38787 | Film No.: 21521826